What question did this study set out to answer?

The study aims to identify and validate prognostic genes related to lipotoxicity in thyroid carcinoma.

April 11, 2026BMC CancerOpen Access

Transcriptome and experimental validation identify prognostic genes associated with lipotoxicity in thyroid carcinoma

View Full Paper

Ask AI

Bookmark

Authors

Experimental validation identifies lipotoxicity-related prognostic genes in thyroid carcinoma, implying their potential as therapeutic targets.

The study aims to identify and validate prognostic genes related to lipotoxicity in thyroid carcinoma.
Integrated transcriptomic and clinical data from The Cancer Genome Atlas
Developed a prognostic model using Cox regression and machine learning
Assessed performance based on immune microenvironment and drug sensitivity
Validated gene expression through RT-qPCR in clinical samples
IL11 and SNAI1 were identified as prognostic markers
High-risk group showed elevated mortality rates
Constructed nomogram demonstrated strong predictive accuracy
Analysis revealed heightened sensitivity to cisplatin and gefitinib in the high-risk group
RT-qPCR confirmed abnormal expression levels of IL11 and SNAI1 in THCA tissues

Lin et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Experimental validation identifies lipotoxicity-related prognostic genes in thyroid carcinoma, implying their potential as therapeutic targets.